1. Home
  2. TZUP vs SCYX Comparison

TZUP vs SCYX Comparison

Compare TZUP & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TZUP
  • SCYX
  • Stock Information
  • Founded
  • TZUP 2020
  • SCYX 1999
  • Country
  • TZUP United States
  • SCYX United States
  • Employees
  • TZUP N/A
  • SCYX N/A
  • Industry
  • TZUP
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TZUP
  • SCYX Health Care
  • Exchange
  • TZUP NYSE
  • SCYX Nasdaq
  • Market Cap
  • TZUP 48.0M
  • SCYX 40.9M
  • IPO Year
  • TZUP N/A
  • SCYX 2014
  • Fundamental
  • Price
  • TZUP $7.97
  • SCYX $0.95
  • Analyst Decision
  • TZUP
  • SCYX
  • Analyst Count
  • TZUP 0
  • SCYX 0
  • Target Price
  • TZUP N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • TZUP 223.0K
  • SCYX 72.8K
  • Earning Date
  • TZUP 01-01-0001
  • SCYX 05-27-2025
  • Dividend Yield
  • TZUP N/A
  • SCYX N/A
  • EPS Growth
  • TZUP N/A
  • SCYX N/A
  • EPS
  • TZUP N/A
  • SCYX N/A
  • Revenue
  • TZUP $741.00
  • SCYX $3,746,000.00
  • Revenue This Year
  • TZUP N/A
  • SCYX $460.12
  • Revenue Next Year
  • TZUP N/A
  • SCYX $253.87
  • P/E Ratio
  • TZUP N/A
  • SCYX N/A
  • Revenue Growth
  • TZUP N/A
  • SCYX N/A
  • 52 Week Low
  • TZUP $2.02
  • SCYX $0.73
  • 52 Week High
  • TZUP $9.20
  • SCYX $3.07
  • Technical
  • Relative Strength Index (RSI)
  • TZUP N/A
  • SCYX 48.25
  • Support Level
  • TZUP N/A
  • SCYX $0.93
  • Resistance Level
  • TZUP N/A
  • SCYX $1.00
  • Average True Range (ATR)
  • TZUP 0.00
  • SCYX 0.06
  • MACD
  • TZUP 0.00
  • SCYX -0.00
  • Stochastic Oscillator
  • TZUP 0.00
  • SCYX 11.76

About TZUP THUMZUP MEDIA CORP

Thumzup Media Corp operates in the social media branding and marketing industry. The company operates in a single business segment which is social media marketing. The Thumzup App works on both iPhone and Android mobile operating systems and connects brands and people who use and love these brands. The easy-to-use dashboard allows advertisers to programmatically customize their campaigns. Cash payments are made to App users/creators through Venmo and PayPal.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: